Cointime

Mimetas

company

About

MIMETAS develops organ-on-a-chip tissue- and disease models for better, more reliable, and tailored medicines.

  • 101 - 250

Highlights

Total Funding Amount
$25.70M
Funding Rounds
2
Investors
3

Details

Last Funding Type
Series B
Last Funding Money Raised
$20.50M
Industries
3D Technology,Biotechnology,Health Care,Information Technology
Founded date
Jan 1, 2013
Number Of Employee
101 - 250
Operating Status
Active

MIMETAS develops predictive Organ-on-a-Chip cell culture models for better, more reliable and tailored medicines. A significant gap exist between the predictive value of various in vitro and animal screening models and a patient. MIMETAS fills this gap with its OrganoPlates featuring organotypic screening models that have an improved predictability and can be screened at a high throughput.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$25.70M
Mimetas has raised a total of $25.70M in funding over 2 rounds. Their latest funding was raised on Apr 11, 2018 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Apr 11, 2018 Series B $20.50M 2 — — Detail
Oct 8, 2014 Series A $5.20M 1 — — Detail

Investors

Number of Lead Investors
Number of Investors
—
3
Mimetas is funded by 3 investors. Cathay Venture and European Life Sciences Growth Fund are the most recent investors.
Investor Name Lead Investor Funding Round
Cathay Venture — Series B
European Life Sciences Growth Fund — Series B
Zeeuws Investerings Fonds — Series A
Cointime
Chủ Đề
Công Ty